Special NoticePosted Aug 5, 2026·Responses due Aug 10, 2026

AN41--Research Services Neural Stem Cell Study for Spinal Cord Injury Pre-solicitation Notice with Intent to Sole Source

Veterans Affairs · RPO EAST (36C24E)

Stage
Early notice (sources sought, presolicitation or special notice)
NAICS
541380
Value
Not stated
Solicitation
36C24E26R0021
Set-aside
None stated
PSC
AN41
Place
Not stated
Contact
Ann Marie Stewart (annmarie.stewart@va.gov)
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation 36C24E26R0021 in this department, oldest first.

Early notice
  • Jul 29, 2026
    Sources Sought
    Open
  • Aug 5, 2026
    Special Notice
    Open
  • Aug 5, 2026 · this notice
    Special Notice
Solicitation
None posted
Award
  • Sep 17, 2026
    Award Notice
    PHARMARON (SAN DIEGO) LAB SERVICES LLC · $1.1M
    Open
Other notices
  • Sep 17, 2026
    Justification (Sole Source)
    PHARMARON (SAN DIEGO) LAB SERVICES LLC · $1.1M
    Open

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Answer the notice: this is when the requirement can still be shaped.
  • Contact the contracting officer named on the notice.
  • Check who won similar work; they are the likely bidders.

What the notice says

Special Notice Special Notice Page 3 of 3 Special Notice Special Notice Page 1 of 3 Pre-Solicitation Notice for notice of intent to award a sole source contract. This is not a solicitation. The Department of Veterans Affairs intends to negotiate a sole source contract for a one (1) year period with Pharmaron (San Diego) Lab Services LLC, 2820 Loker Ave E, Carlsbad CA 92010 to provide In vivo safety of neural stem cells grafted in rats with spinal cord injury. The vendor will be responsible for all aspects of the rat for the In Vivo GLP study performed in full compliance with FDA 21 CFR Part 58… (show all)

, Good Laboratory Practice (GLP) for Nonclinical Laboratory Studies. Rats will be subjected to a spinal cord injury, followed by a neural stem cell or control graft and will be sacrificed at 1, 3, or 9 months post-graft. The Vendor will be responsible for master study protocol, animal procurement, surgical and post-surgical support, animal perfusion and generation of a final GLP study report adhering to FDA 21 CFR Part 58, Good Laboratory Practice for Nonclinical Laboratory Studies guidelines. The facility must be in driving distance to the VA San Diego to maintain scientific integrity of stem cells with time-sensitive transportation (cells that are transplanted into these animals are prepared in house and must be hand-delivered on ice) and to limit long-distance travel. These requirements are critical to support regulatory submission and clinical translation of therapies addressing spinal cord injury in the Veteran population. The required highly specialized services directly support development of therapies for spinal cord injury (SCI), a condition disproportionately affecting Veterans. The complexity of neural stem cell therapies introduces heightened regulatory scrutiny, particularly regarding safety and long-term persistence in central nervous system tissues. Given Pharmaron s proximity to the San Diego VA Medical Center, its extensive expertise in stem cell based therapies, and its ability to provide the complete suite of required capabilities within a single, integrated framework specific to neural stem cell based CNS applications, Pharmaron is the only vendor capable of conducting the GLP study necessary to evaluate the safety, toxicity, and biodistribution of grafting a GMP H9 scNSC Working Cell Bank (WCB) in vivo into athymic rats within the required timeline for the ongoing research efforts. Accordingly, this requirement will be procured on a sole source basis, and no solicitation will be posted on SAM.gov Contract Opportunities. The applicable NAICS code is 541380 (Testing Laboratories and Services), with a $19 million size standard. The Product Service Code (PSC) is AN41. The authority for this action is RFO 6.103-1; Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements. Interested parties may submit inquiries regarding this notice by email only to: Ann Marie Stewart Contracting Officer Email: annmarie.stewart@va.gov The VA will consider all responses received; however, the decision to conduct a competitive procurement based on responses to this notice is solely at the discretion of the Contracting Officer.

Who won similar work

5 award notices on SAM.gov in the last 24 months. Match: Same office, same NAICS 541380.

WinnerAwardsValueLast
TEMPUS AI, INC · $TEM1$35.2MFeb 11, 2026
INFINITY BIOLOGIX LLC1$27.1MFeb 27, 2026
METABOLON, INC.1$22.0MSep 17, 2026
Rutgers, The State University NEWARK 07103 JIB1$1.3MAug 24, 2026
THE JOHNS HOPKINS UNIVERSITY Baltimore MD 21218 USA1$624KSep 25, 2026

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in.

Latest awards

Competitive landscape

For the 5 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 0 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (0 filings)
  • 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
  • No corporate PAC money from them to the overseeing committees since 2024
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 0 bills named on the past winners' lobbying filings
  • 25 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards.

  • 1 of the past winners are listed companies
  • 0 insider buys and 21 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.